Skip to content

On-site fabrication of injectable 131I-labeled microgels for local radiotherapy

On-site fabrication of injectable I-131-labeled microgels for local radiotherapy

Document Type
Publications · Journal Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q1Scopus Q1
Journal
JOURNAL OF CONTROLLED RELEASE322 · pp.337 · 2020
Citation
Web of Science 25Scopus 25
FWCI (Scopus)
0
JCR IF
JCR 2019 7.727
ISSN
0168-3659

Authors

  1. Kim SodamFirst authorDepartment of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
  2. Sang-Gu YimDepartment of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
  3. Chandrasekharan, AjeeshDepartment of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
  4. Sung, Geum YongDepartment of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
  5. Tae Wook LeeDepartment of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
  6. Kim, ByeongyeonDepartment of Biomedical Engineering, Hanyang University, Seoul 04763, Republic of Korea
  7. Kim, KeunyoungCorresponding authorDepartment of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea
  8. Choi, SungyoungDepartment of Biomedical Engineering, Hanyang University, Seoul 04763, Republic of Korea
  9. Yang, SeungyounDepartment of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea

Abstract

Nuclear medicine is a routine but essential clinical option for diagnostic imaging and disease treatment. Encapsulating radioisotopes in injectable biodegradable hydrogels is ideal for localizing radiation sources to target tissues or organs to achieve long-term, low-dose radiotherapy. However, difficulties in the on-site production of radioactive gels upon treatment and the unpredictable radiation level at the target region are major obstacles to their clinical use. In this study, we bypassed these limitations by developing locally injectable hydrogel microparticles based on I-131-labeled photo-crosslinkable hyaluronic acid (HA) and a microfluidic highthroughput droplet generator. This approach enabled rapid on-site production of injectable, radioactive, biodegradable (IRB) HA microgels, thus allowing their immediate therapeutic application with improved local retention and predictable radioactivity. We demonstrated the clinical utility of this comprehensive approach by preparing IRB HA microgels within 15 min and localizing them to the target tissue (rat muscle) with minimal offtarget biodistribution and in vivo radioactivity that extended beyond 3 weeks.

Keywords

Injectable drug delivery systemRadiotherapyHyaluronic acidI-131Hydrogel microparticleCENTRIFUGAL STEP EMULSIFICATIONIN-SITUSEED IMPLANTATIONRADIATIONHYDROGELTHERAPYI-125BIODISTRIBUTIONEMULSIONSDELIVERY131I

Identifiers

Scopus EID
2-s2.0-85082723754
WoS UID
000537134400001